Literature DB >> 31463521

[Rhinoviruses].

A Grünewaldt1, C Hügel1, G G U Rohde2.   

Abstract

Human rhinoviruses (RV) belong to the Picornaviridae and are divided into three species: rhinovirus A, B and C. As causative viruses of upper airway infections (common cold), they possess enormous epidemiological and clinical importance. Furthermore, rhinoviruses are significant pathogens of acute exacerbations of chronic airway diseases such as asthma and chronic obstructive pulmonary disease. Their role as a cofactor in the development of pneumonia and their relevance in critically ill patients is still unclear and the focus of current research. Due to the unspecific clinical symptoms, diagnosis is difficult. Laboratory detection is sophisticated and a distinction between clinically relevant infection and contamination not always possible. Specific therapeutic antiviral strategies against rhinovirus infection do not exist as yet and, due to the large variety of subtypes, the development of vaccines remains a considerable challenge.

Entities:  

Keywords:  Antiviral agents; Disease exacerbation, viral; Picornaviridae; Pneumonia; Respiratory tract infection

Mesh:

Substances:

Year:  2019        PMID: 31463521     DOI: 10.1007/s00108-019-00672-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  42 in total

1.  Rhinoviruses infect the lower airways.

Authors:  N G Papadopoulos; P J Bates; P G Bardin; A Papi; S H Leir; D J Fraenkel; J Meyer; P M Lackie; G Sanderson; S T Holgate; S L Johnston
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

2.  A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.

Authors:  Jinwoo Kim; Yu Kyoung Jung; Chonsaeng Kim; Jin Soo Shin; Els Scheers; Joo-Youn Lee; Soo Bong Han; Chong-Kyo Lee; Johan Neyts; Jae-Du Ha; Young-Sik Jung
Journal:  J Med Chem       Date:  2017-06-15       Impact factor: 7.446

Review 3.  Rhinoviruses and Their Receptors.

Authors:  Sarmila Basnet; Ann C Palmenberg; James E Gern
Journal:  Chest       Date:  2019-01-17       Impact factor: 9.410

4.  Respiratory virus infection of monolayer cultures of human nasal epithelial cells.

Authors:  B Winther; J M Gwaltney; J O Hendley
Journal:  Am Rev Respir Dis       Date:  1990-04

5.  Community-acquired pneumonia requiring hospitalization among U.S. children.

Authors:  Seema Jain; Derek J Williams; Sandra R Arnold; Krow Ampofo; Anna M Bramley; Carrie Reed; Chris Stockmann; Evan J Anderson; Carlos G Grijalva; Wesley H Self; Yuwei Zhu; Anami Patel; Weston Hymas; James D Chappell; Robert A Kaufman; J Herman Kan; David Dansie; Noel Lenny; David R Hillyard; Lia M Haynes; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Richard G Wunderink; Kathryn M Edwards; Andrew T Pavia; Jonathan A McCullers; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

6.  Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.

Authors:  G Rohde; A Wiethege; I Borg; M Kauth; T T Bauer; A Gillissen; A Bufe; G Schultze-Werninghaus
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

7.  Inhibition of Pim1 kinase, new therapeutic approach in virus-induced asthma exacerbations.

Authors:  Maaike de Vries; Nicole Bedke; Natalie P Smithers; Matthew Loxham; Peter H Howarth; Martijn C Nawijn; Donna E Davies
Journal:  Eur Respir J       Date:  2016-02-11       Impact factor: 16.671

8.  Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbations.

Authors:  David J Jackson; Nicholas Glanville; Maria-Belen Trujillo-Torralbo; Betty W H Shamji; Jerico Del-Rosario; Patrick Mallia; Matthew J Edwards; Ross P Walton; Michael R Edwards; Sebastian L Johnston
Journal:  Clin Infect Dis       Date:  2015-02-02       Impact factor: 9.079

9.  Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus.

Authors:  Aurélie Mousnier; Andrew S Bell; Dawid P Swieboda; Julia Morales-Sanfrutos; Inmaculada Pérez-Dorado; James A Brannigan; Joseph Newman; Markus Ritzefeld; Jennie A Hutton; Anabel Guedán; Amin S Asfor; Sean W Robinson; Iva Hopkins-Navratilova; Anthony J Wilkinson; Sebastian L Johnston; Robin J Leatherbarrow; Tobias J Tuthill; Roberto Solari; Edward W Tate
Journal:  Nat Chem       Date:  2018-05-14       Impact factor: 24.427

Review 10.  [Treatment for viral respiratory infections: Principles of action, strategies, and future prospects].

Authors:  G Rohde; G Schultze-Werninghaus; T T Bauer
Journal:  Internist (Berl)       Date:  2004-04       Impact factor: 0.743

View more
  1 in total

Review 1.  Mechanism of Rhinovirus Immunity and Asthma.

Authors:  Zuqin Yang; Hannah Mitländer; Tytti Vuorinen; Susetta Finotto
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.